Home
>
National Drug Code (NDC)
>
VANIQA
VANIQA - 0023-4857-45 - (eflornithine hydrochloride)
Drug Information of VANIQA
| Product NDC: | 0023-4857 |
| Proprietary Name: | VANIQA |
| Non Proprietary Name: | eflornithine hydrochloride |
| Active Ingredient(s): | 139 mg/g & nbsp; eflornithine hydrochloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VANIQA
| Product NDC: | 0023-4857 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021145 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130601 |
Package Information of VANIQA
| Package NDC: | 0023-4857-45 |
| Package Description: | 1 TUBE in 1 CARTON (0023-4857-45) > 45 g in 1 TUBE |
NDC Information of VANIQA
| NDC Code | 0023-4857-45 |
| Proprietary Name | VANIQA |
| Package Description | 1 TUBE in 1 CARTON (0023-4857-45) > 45 g in 1 TUBE |
| Product NDC | 0023-4857 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | eflornithine hydrochloride |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20130601 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | EFLORNITHINE HYDROCHLORIDE |
| Strength Number | 139 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Antiprotozoal [EPC],Decarboxylase Inhibitor [EPC],Decarboxylase Inhibitors [MoA] |
